Most Popular White Papers
Content provided in partnership with
Business Services Industry
ALCON DEVELOPS NEW FORMULATION OF PATANOL OPHTHALMIC SOLUTION.
AsiaPulse News, January, 2003
 |
$all $us $anr $dru
(Full text of a statement. Contact details below.)
FORT WORTH, Texas, Jan. 23 /PRNewswire-FirstCall-Asianet/ -- Alcon, Inc. (NYSE: ACL) will present the results from two clinical trials involving a new, investigational once-daily formulation of the company's flagship brand PATANOL(R) at the annual meeting of the Western Society of Allergy, Asthma & Immunology (WSAAI) in Hawaii this week.
The first study investigated the product's safety and efficacy up to 24 hours after dosing, while the second evaluated the safety of the drug. This new formulation of PATANOL solution is intended for the once-daily ...
Find Research Guides for:
Find Featured Titles for: Arts
Most Popular Articles in Business
- Research and Markets : Tesco Plc - SWOT Framework Analysis
- Do Us a Flavor - Ben & Jerry's Issues a Call for Euphoric New Flavors
- eBay made easy: ready to start an eBay business? These 5 simple steps will ...
- Katrina's lawsuit surge: a legal battle to force insurers to pay for flood ...
- Wal-Mart's newest distribution center opened last month near the southwest ...
- More »